Top news of the week: 21.07.2020.
Drug, Biotechnology, Initial public offering, Dot-com bubble, Antibody, Economics
Startups
RT @LifeSciVC: Record-Breaking Biotech Funding Tsunami Of 1H2020
Largest amount of quarterly VC funding ever.
Largest amount raised in biotech IPOs in a quarter.
Largest total equity capital raised in a quarter.
Hopefully we will make new drugs with it!
https://t.co/5mJmnXEkgY https://t.co/P2irCI35CR
OpenThe Record-Breaking Biotech Funding Tsunami Of 1H2020
We’re half way through one of the craziest years in recent memory, with a raging viral pandemic, civil unrest and protests, staggering unemployment and economic woes, and invasive murder ...
RT @Xconomy: Two Days, Six IPOs, and $1B Raised for Biotech Research & More
- by @frankvinluan
https://t.co/nnb7bpPi1P
$RLAY $PAND $BLI $RNLX $ALXO
OpenTwo Days, Six IPOs, and $1B Raised for Biotech Research & More
Summer’s arrival hasn’t slowed the momentum of the biotech IPO market. Wall Street this week welcomed six new life science industry companies, which
"Through the application of mRNA technology ... we hope to be able to develop and scale up advanced vaccines and therapies to treat and prevent infectious diseases quicker than ever before."
$GSK
https://t.co/Dypg4LpgIo
OpenGSK invests in mRNA vaccines through deal with CureVac
While CureVac's coronavirus work is excluded from the deal, GSK said the biotech's platform should complement its existing vaccine technology and provide greater access to manufacturing.
RT @IAmBiotech: .@McClatchyDC reports on new #coronavirus treatments expected this fall, including insights from BIO’s own VP of Industry Research @DavidThomasCFA on the #COVID19 pipeline. https://t.co/sCPcYHeGP4
OpenNew coronavirus treatments are expected this fall. But how powerful will they be?
Scientists are hopeful that new drugs will be available to help lower the COVID-19 death toll and burden on intensive care units in hospitals.
RT @GVteam: Congratulations to the @Relay_Tx team on today's IPO! GV's @kyeshwant reflects on the company's milestone – https://t.co/eTP3PS5aFA
OpenRelay Therapeutics: The 100-Year Race towards Better Drug Discovery
Relay's technology can visualize and target moving proteins in the human body. By identifying and simulating the underlying proteins that cause disease, Relay can design better drugs to ...
RT @PitchBookNews: "Mega-rounds and mega-funds have been the name of the game in recent months, with VCs and LPs pumping an increasing percentage of their cash into established names."
@KevinDowd breaks down US VC trends through the first half of 2020 in his weekly recap: https://t.co/4KcqszpGzf
Open11 big things: VCs hunt for knowns in a great unknown
New data from venture capital's first half of the year joins newspaper news, Oprah's oak-milk investment and more in our recap of the week.
A British biotech company could be benefiting from ticker confusion with Tesla https://t.co/Ff219Nm2PU
OpenA British biotech company could be benefiting from ticker confusion with Tesla
Traders may be boosting the value of Tiziana Life Sciences by mistake due to its ticker's similarity to Tesla's, Bloomberg first reported Wednes...
ICYMI earlier: A #startup launches with big plans to develop antibody drugs for coronaviruses https://t.co/Rf0elpzdmC #COVID19 $REGN $LLY $AZN $ABBV $AMGN $VIR
OpenA startup launches with big plans to develop antibody drugs for coronaviruses
Larger drugmakers like Regeneron have led the way in developing antibody drugs for COVID-19. Adagio Therapeutics aims to prove it can follow suit, with an eye to future coronavirus ...